Aim To investigate the role of hypoxia-preconditioned mesenchymal stem cells (H-MSCs) in preventing peritoneal adhesion by regulating IL-6 at days 6 and 12. Methods Twenty-four PAs rat model weighing 250 g to 300 g were randomly allocated into 4 groups: sham (Sh), control (C), H-MSCs treatment group at dose 1.5 x 106 (T1) and 3 x 106 (T2). To induce H-MSCs, all MSCs population were incubated under hypoxia state (5% O2), 5% CO2, and 37o C for 24 hours. Expression level of IL-6 was performed using ELISA. Morphological appearance of adhesion was observed by visualizing the existence of adhesion formation in intestinal. Results In this study we found that there was a trend of decrease of IL-6 level on day 6 following MSCs treatments. Interestingly, there was a significant decrease of IL-6 level on day 12 in all treatment groups. Also, no adhesion occurred in T2 group. Conclusions H-MSCs prevent PA development by suppressing the prolonged release of IL-6 at proliferation phase.
Lin H, Xu L, Yu S. Therapeutics targeting the fibrinolytic system. Exp Mol Med 2020:367–79.
2
Pankajakshan D, Agrawal D. Mesenchymal stem cell paracrine factors in vascular repair and regeneration. J Biomed Technol Res 2014:1.
3
West N. Coordination of immune-stroma crosstalk by il-6 family cytokines. Front Immunol 2019:1093.
4
Kuhn K, Manieri N, Liu T, Stappenbeck T. IL-6 stimulates intestinal epithelial proliferation and repair after injury. PLoS One 2014:114195.
5
Rocca A, Aprea G, Surfaro G, Amato M, Giuliani A, Paccone M, et al. Prevention and treatment of peritoneal adhesions in patients affected by vascular diseases following surgery: a review of the literature. Open Med (Wars) 2016:106–14.
6
Jafari-Sabet M, Shishegar A, Saeedi A, Ghahari S. Pentoxifylline Increases Antiadhesion Effect of Streptokinase on Postoperative Adhesion Formation: Involvement of Fibrinolytic Pathway. Indian J Surg 2015;(Suppl 3):837–42.
7
Xu W, Xu R, Li Z, Wang Y, Hu R. Hypoxia changes chemotaxis behaviour of mesenchymal stem cells via HIF-1α signalling. J Cell Mol Med 2019;(3):1899–907.
8
Capella-Monsonís H, Kearns S, Kelly J, Zeugolis D. Battling adhesions: from understanding to prevention. BMC Biomed Eng 2019:5.
9
Mutsaers S, Birnie K, Lansley S, Herrick S, Lim C, Prêle C. Mesothelial cells in tissue repair and fibrosis. Front Pharmacol 2015:113.
10
Ikhsan R, Putra A, Munir D, Darlan D, Suntoko B, Retno A. Mesenchymal stem cells induce regulatory T-cell population in human SLE. Bangladesh J Med Sci 2020:743–8.
11
Trisnadi S, Muhar A, Putra A, Kustiyah. AR. Hypoxia-preconditioned mesenchymal stem cells attenuate peritoneal adhesion through TGF-β inhibition. Univ Med 2020:97–104.
12
Kim Y. Comparative study for preventive effects of intra-abdominal adhesion using cyclo-oxygenase-2 enzyme (COX-2) inhibitor, low molecular weight heparin (LMWH), and synthetic barrier. Yonsei Med J 2013:1491–7.
13
Muhar A, Putra A, Warli S, Delfitri M. Hypoxia-mesenchymal stem cells inhibit intra-peritoneal adhesions formation by upregulation of the IL-10 expression. Open Access Maced J Med Sci 2019:3937–43.
14
Zubaidi A, Hussain T, Alzoghaibi M. The time course of cytokine expressions plays a determining role in faster healing of intestinal and colonic anastomatic wounds. Saudi J Gastroenterol 2015:412–7.
15
Dan Pengembangan. We would also like to thank the Stem Cell and Cancer Research Laboratory, Medical Faculty, Universitas Islam Sultan Agung Semarang for all facilities to finish this research. FUNDING DRPM Contract 2020.
16
Capella-Monsonís H, Kearns S, Kelly J, Dimitrios. Battling adhesions: from understanding to prevention. BMC Biomed Eng 2019:5.
17
Cronjé H, Nienaber-Rousseau C, Zandberg L, De Lange Z, Green F, Pieters M. Fibrinogen and clot-related phenotypes determined by fibrinogen polymorphisms: Independent and IL-6-interactive associations. PLoS One 2017:11.
18
Mutsaers S, Prêle C, Pengelly S, Herrick S. Mesothelial cells and peritoneal homeostasis. Fertil Steril 2016:1018–24.
19
Samsonraj R, Rai B, Sathiyanathan P, Puan K, Rötzschke O, Hui J, et al. Establishing criteria for human mesenchymal stem cell potency. Stem Cells 2015:1878–91.
20
Fábián Z. The Effects of hypoxia on the immunemodulatory properties of bone marrow-derived mesenchymal stromal cells. Stem Cells Int 2019:2509606.
21
Almeria C, Weiss R, Roy M, Tripisciano C, Kasper C, Egger W, et al. Hypoxia conditioned mesenchymal stem cell-derived extracellular vesicles induce increased vascular tube formation in vitro. Front Bioeng Biotechnol 2019:292.
22
Putra A, Pertiwi D, Milla M, Indrayani U, Jannah D, Sahariyani M, et al. Hypoxiapreconditioned MSCs have superior effect in ameliorating renal function on acute renal failure animal model. Open Access Maced J Med Sci 2019:305–10.
23
Li P, Gong Z, Shultz L, Ren G. Mesenchymal stem cells: from regeneration to cancer. Pharmacol Ther 2019:42–54.
24
Xue X, Falcon D. The role of immune cells and cytokines in intestinal wound healing. Int J Mol Sci 2019:6097.
25
Baker S, S. Review: A critical role for plasminogen in inflammation. J Exp Med 2020:4.
26
Bester J, Pretorius E. Effects of IL-1β, IL-6 and IL-8 on erythrocytes, platelets and clot viscoelasticity. Sci Rep 2016:32188.
27
Weisel J, Litvinov R. Fibrin formation, structure and properties. Subcell Biochem 2017:405–56.
28
Thorbjörn S, Malin C, Urban K. Mechanisms of adhesive small bowel obstruction and outcome of surgery; a population-based study. BMC Surgery 2020:62.
29
Broek T, Krielen R, P, Saverio D, S. Bologna guidelines for diagnosis and management of adhesive small bowel obstruction (ASBO): 2017 update of the evidence-based guidelines from the world society of emergency surgery ASBO working group. World J Emerg Surg 2018:24.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
,
